Literature DB >> 3396258

The effect of a plasma protein fraction on lipid synthesis in cultured skin fibroblasts from normals and patients with hyperapobetalipoproteinemia.

K Cianflone1, M A Rodriguez, M Walsh, H Vu, A D Sniderman.   

Abstract

Lipid synthesis was measured in cultured skin fibroblasts obtained from normals and patients with Hyperapobetalipoproteinemia (HyperapoB). Using lipoprotein-deficient serum medium, triglyceride synthesis and cholesterol esterification were greater in normals than in HyperapoB due to differences in de novo synthesis, not to differences in re-esterification or to different rates of hydrolysis. When normal and HyperapoB cells were incubated in serum-free medium, however, lipid synthesis was the same. Serum was then fractionated chromatographically and a partially purified protein fraction shown to be responsible for the stimulatory effect in normals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396258

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.

Authors:  K M Cianflone; M H Maslowska; A D Sniderman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 2.  Complement-Mediated Regulation of Metabolism and Basic Cellular Processes.

Authors:  Christoph Hess; Claudia Kemper
Journal:  Immunity       Date:  2016-08-16       Impact factor: 31.745

3.  Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue.

Authors:  Z Yasruel; K Cianflone; A D Sniderman; M Rosenbloom; M Walsh; M A Rodriguez
Journal:  Lipids       Date:  1991-07       Impact factor: 1.880

4.  The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis.

Authors:  A Baldo; A D Sniderman; S St-Luce; R K Avramoglu; M Maslowska; B Hoang; J C Monge; A Bell; S Mulay; K Cianflone
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 5.  Complement--tapping into new sites and effector systems.

Authors:  Martin Kolev; Gaelle Le Friec; Claudia Kemper
Journal:  Nat Rev Immunol       Date:  2014-11-14       Impact factor: 53.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.